Long-acting Reversible Contraception for Adolescents

Overview

Journal Curr Opin Obstet Gynecol

Specialty Gynecology & Obstetrics

Date 2012 Jul 12

PMID 22781078

Citations 15

Authors

Colleen McNicholas

Jeffrey F Peipert

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Teen pregnancy continues to plague the United States. This review will discuss long-acting reversible contraceptive (LARC) method use in teens, comprising intrauterine devices and subdermal implants.

Recent Findings: The American College of Obstetricians and Gynecologists along with the American Academy of Pediatrics, the Centers for Disease Control, and the World Health Organization have recognized the potential impact of LARC (comprising intrauterine contraception and subdermal implants) to reduce unintended pregnancies. They have affirmed the safety of such devices, and no effects on long-term fertility have been identified. Teen users of these methods have been shown to have high continuation and satisfaction rates. On the contrary, oral contraceptive pills, the patch, and the contraceptive vaginal ring have significantly higher contraceptive failure rates, and these rates are magnified in young women.

Summary: LARC methods should be considered first-line options for teens seeking contraception.

Citing Articles

Knowledge of and access to contraceptive information and services among teenagers with child welfare involvement: A descriptive study across the transition to high school.

Combs K, Racz S, Taussig H Child Youth Serv Rev. 2024; 166.

PMID: 39650334 PMC: 11619765. DOI: 10.1016/j.childyouth.2024.108004.

Factors associated with long-acting reversible contraceptives usage among sexually active adolescent girls and young women in Zimbabwe.

Chipako I, Singhal S, Hollingsworth B PLOS Glob Public Health. 2024; 4(8):e0003551.

PMID: 39163319 PMC: 11335097. DOI: 10.1371/journal.pgph.0003551.

Factors associated with unintended pregnancy and contraceptive practices in justice-involved adolescent girls in Australia.

Smith H, Wilson M, Donovan B, Jones J, Butler T, Nathan S PLoS One. 2024; 19(6):e0304825.

PMID: 38889164 PMC: 11185493. DOI: 10.1371/journal.pone.0304825.

Why-UD? Assessing the requirement to trial an intrauterine device as a condition for elective sterilisation in female patients.

Baron T J Med Ethics. 2023; 50(10):708-711.

PMID: 38124158 PMC: 11503051. DOI: 10.1136/jme-2023-109264.

Impact of polymer crosslinking on release mechanisms from long-acting levonorgestrel intrauterine systems.

Fanse S, Bao Q, Zou Y, Wang Y, Burgess D Int J Pharm. 2021; 612:121383.

PMID: 34919997 PMC: 9208241. DOI: 10.1016/j.ijpharm.2021.121383.

References

Martinez G, Copen C, Abma J . Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. Vital Health Stat 23. 2012; (31):1-35. View

Nilsson C, Haukkamaa M, Vierola H, LUUKKAINEN T . Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol (Oxf). 1982; 17(6):529-36. DOI: 10.1111/j.1365-2265.1982.tb01625.x. View

Kiriwat O, Patanayindee A, Koetsawang S, Korver T, Bennink H . A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand. Eur J Contracept Reprod Health Care. 1998; 3(2):85-91. DOI: 10.3109/13625189809051409. View

Winner B, Peipert J, Zhao Q, Buckel C, Madden T, Allsworth J . Effectiveness of long-acting reversible contraception. N Engl J Med. 2012; 366(21):1998-2007. DOI: 10.1056/NEJMoa1110855. View

Blanc A, Tsui A, Croft T, Trevitt J . Patterns and trends in adolescents' contraceptive use and discontinuation in developing countries and comparisons with adult women. Int Perspect Sex Reprod Health. 2009; 35(2):63-71. DOI: 10.1363/ipsrh.35.063.09. View

Trussell J, Lalla A, Doan Q, Reyes E, Pinto L, Gricar J . Cost effectiveness of contraceptives in the United States. Contraception. 2008; 79(1):5-14. PMC: 3638200. DOI: 10.1016/j.contraception.2008.08.003. View

Mosher W, Chandra A, Jones J . Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data. 2005; (362):1-55. View

Sivin I, Stern J, Diaz S, Pavez M, Alvarez F, Brache V . Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol. 1992; 166(4):1208-13. DOI: 10.1016/s0002-9378(11)90607-3. View

Vessey M, Lawless M, McPherson K, Yeates D . Fertility after stopping use of intrauterine contraceptive device. Br Med J (Clin Res Ed). 1983; 286(6359):106. PMC: 1546405. DOI: 10.1136/bmj.286.6359.106. View

10.

Darroch J, Singh S, Frost J . Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use. Fam Plann Perspect. 2002; 33(6):244-50, 281. View

11.

Baldaszti E, Wimmer-Puchinger B, Loschke K . Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception. 2003; 67(2):87-91. DOI: 10.1016/s0010-7824(02)00482-1. View

12.

Affandi B, Korver T, Geurts T, Coelingh Bennink H . A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for < or = 4 years. Contraception. 1999; 59(3):167-74. DOI: 10.1016/s0010-7824(99)00015-3. View

13.

Finer L, Zolna M . Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011; 84(5):478-85. PMC: 3338192. DOI: 10.1016/j.contraception.2011.07.013. View

14.

Saav I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007; 22(10):2647-52. DOI: 10.1093/humrep/dem244. View

15.

Alvarez F, Brache V, Fernandez E, Guerrero B, GUILOFF E, Hess R . New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril. 1988; 49(5):768-73. View

16.

Hubacher D, Grimes D . Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv. 2002; 57(2):120-8. DOI: 10.1097/00006254-200202000-00024. View

17.

Santelli J, Lindberg L, Finer L, Singh S . Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health. 2006; 97(1):150-6. PMC: 1716232. DOI: 10.2105/AJPH.2006.089169. View

18.

Andersson J, RYBO G . Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990; 97(8):690-4. DOI: 10.1111/j.1471-0528.1990.tb16240.x. View

19.

Mestad R, Secura G, Allsworth J, Madden T, Zhao Q, Peipert J . Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011; 84(5):493-8. PMC: 3505875. DOI: 10.1016/j.contraception.2011.03.001. View

20.

Dijkhuizen K, Dekkers O, Holleboom C, de Groot C, Hellebrekers B, van Roosmalen G . Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod. 2010; 26(2):323-9. DOI: 10.1093/humrep/deq348. View